Insider transactions

EDGAR

Lionsgate Studios Corp.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
7 transactions, 42,600,497 shares
7 without a price are not valued.
Open-market sales (code S)
8 transactions, 42,842,245 shares
Sum of shares × price per share: 2,024,049.48 5 without a price are not valued.

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 122

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-09-15 Filed 2026-09-17SLOAN HARRY Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)13,4050—429,318Direct (D) No
F1, F2
  • F1 Annual director equity award.
  • F2 Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,107 restricted share units that are scheduled to vest on November 28, 2026; and (ii) 13,405 restricted share units that are scheduled to vest on September 15, 2027.
Open filing 0001258248-26-000014 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17SLOAN HARRY Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)5,36211.19
60,000.78

Derived: shares × price per share. Exact value 60000.78.

434,680Direct (D) No
F3, F2
  • F3 Director fees paid in common shares.
  • F2 Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,107 restricted share units that are scheduled to vest on November 28, 2026; and (ii) 13,405 restricted share units that are scheduled to vest on September 15, 2027.
Open filing 0001258248-26-000014 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Crawford Gordon Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)13,4050—2,259,635Direct (D) No
F1, F2
  • F1 Annual director equity award.
  • F2 Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,107 restricted share units that are scheduled to vest on November 28, 2026; and (ii) 13,405 restricted share units that are scheduled to vest on September 15, 2027.
Open filing 0001567530-26-000003 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Crawford Gordon Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)4,46811.19
49,996.92

Derived: shares × price per share. Exact value 49996.92.

2,264,103Direct (D) No
F3, F2
  • F3 Director fees paid in common shares.
  • F2 Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,107 restricted share units that are scheduled to vest on November 28, 2026; and (ii) 13,405 restricted share units that are scheduled to vest on September 15, 2027.
Open filing 0001567530-26-000003 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Rosenblatt M Richard Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)13,4050—74,202Direct (D) No
F1, F2
  • F1 Annual director equity award.
  • F2 Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,107 restricted share units that are scheduled to vest on November 28, 2026; and (ii) 13,405 restricted share units that are scheduled to vest on September 15, 2027.
Open filing 0001504471-26-000002 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Rosenblatt M Richard Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)4,46811.19
49,996.92

Derived: shares × price per share. Exact value 49996.92.

78,670Direct (D) No
F3, F2
  • F3 Director fees paid in common shares.
  • F2 Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,107 restricted share units that are scheduled to vest on November 28, 2026; and (ii) 13,405 restricted share units that are scheduled to vest on September 15, 2027.
Open filing 0001504471-26-000002 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Ostolaza Yvette Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)13,4050—161,225Direct (D) No
F1, F2
  • F1 Annual director equity award.
  • F2 Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,107 restricted share units that are scheduled to vest on November 28, 2026; and (ii) 13,405 restricted share units that are scheduled to vest on September 15, 2027.
Open filing 0001796999-26-000002 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Ostolaza Yvette Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)5,36211.19
60,000.78

Derived: shares × price per share. Exact value 60000.78.

166,587Direct (D) No
F3, F2
  • F3 Director fees paid in common shares.
  • F2 Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,107 restricted share units that are scheduled to vest on November 28, 2026; and (ii) 13,405 restricted share units that are scheduled to vest on September 15, 2027.
Open filing 0001796999-26-000002 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17McCaw Susan Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)13,4050—114,431Direct (D) No
F1, F2
  • F1 Annual director equity award.
  • F2 Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,107 restricted share units that are scheduled to vest on November 28, 2026; and (ii) 13,405 restricted share units that are scheduled to vest on September 15, 2027.
Open filing 0001752099-26-000003 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17RACHESKY MARK H MD Director · 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)6,79211.19
76,002.48

Derived: shares × price per share. Exact value 76002.48.

269,004Direct (D) No
F1
  • F1 Director fees granted in Common Shares of the Issuer.
Open filing 0001193125-26-394379 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17RACHESKY MARK H MD Director · 10% owner
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)13,40511.19
150,001.95

Derived: shares × price per share. Exact value 150001.95.

13,405Direct (D) No
F2
  • F2 These are restricted share units granted by the Issuer, payable upon vesting in an equal number of Common Shares, which are scheduled to vest in one annual installment on September 15, 2027.
Open filing 0001193125-26-394379 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17FINE EMILY Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)4,46811.19
49,996.92

Derived: shares × price per share. Exact value 49996.92.

141,256Direct (D) No
F1
  • F1 Director fees granted in Common Shares of the Issuer.
Open filing 0001193125-26-394367 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17FINE EMILY Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)13,40511.19
150,001.95

Derived: shares × price per share. Exact value 150001.95.

13,405Direct (D) No
F2
  • F2 These are restricted share units granted by the Issuer, payable upon vesting in an equal number of Common Shares, which are scheduled to vest in one annual installment on September 15, 2027
Open filing 0001193125-26-394367 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17HARKEY JOHN D JR Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)13,4050—221,593Direct (D) No
F1, F2
  • F1 Annual director equity award.
  • F2 Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,107 restricted share units that are scheduled to vest on November 28, 2026; and (ii) 13,405 restricted share units that are scheduled to vest on September 15, 2027.
Open filing 0001235775-26-000002 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17HARKEY JOHN D JR Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)5,80911.19
65,002.71

Derived: shares × price per share. Exact value 65002.71.

227,402Direct (D) No
F3, F2
  • F3 Director fees paid in common shares.
  • F2 Amount includes the following restricted share units granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 20,107 restricted share units that are scheduled to vest on November 28, 2026; and (ii) 13,405 restricted share units that are scheduled to vest on September 15, 2027.
Open filing 0001235775-26-000002 Read from the filing’s XML Dispute this row
2026-07-08 Filed 2026-07-10RACHESKY MARK H MD Director · 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Shares
Disposed (D)1,469,450——0Indirect (I) See FootnotesNo
F27, F32, F33, F7, F8
  • F27 In connection with that certain continuation fund transaction, as further described in Amendment No. 2 to Schedule 13D filed by the certain of the reporting persons on July 9, 2026 (the CV Transaction), Institutional Partners II contributed the Common Shares held for its account to Sun II and LION Holdco A, in exchange for limited partnership interests in Sun II and limited partnership interests and certain other interests in LION Holdco A. Dr. Rachesky's indirect pecuniary interest in the Common Shares may be deemed to have increased as a result of the transactions described in footnotes (27), (28) and (29) due to Dr. Rachesky and certain of his affiliated entities being investors in an entity that is a limited partner in LION Holdco A and LION Holdco B.
  • F32 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Voting and Standstill Agreement, by and among the Issuer, Liberty Global Ventures Limited, a limited company organized under the laws of England and Wales, Liberty Global Ltd., Bermuda exempted company limited by shares, Discovery Lightning Investments Ltd., a limited company organized under the laws of England and Wales, Warner Bros. Discovery, Inc., a Delaware corporation, Master Account, Capital Partners (100), Institutional Partners II, Institutional Partners IIA, Institutional Partners III, Institutional Partners IV and Fund Management, but as to which they have no pecuniary interest.
  • F33 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Governance, Standstill and Voting Agreement, by and among Fund Management and certain of its affiliates and Liberty 77 Capital L.P., a Delaware limited partnership, Liberty 77 Fund L.P., a Cayman Islands exempted limited partnership and Liberty 77 Fund International L.P., a Cayman Islands exempted limited partnership, but as to which they have no pecuniary interest.
  • F7 These Common Shares are held for the account of MHR Institutional Partners II LP, a Delaware limited partnership (Institutional Partners II). MHR Institutional Advisors II LLC, a Delaware limited liability company (Institutional Advisors II), is the general partner of Institutional Partners II. MHRC II LLC, a Delaware limited liability company (MHRC II), is the managing member of Institutional Advisors II. Dr. Rachesky is the managing member of MHRC II. Fund Management has an investment management agreement with Institutional Partners II pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the Common Shares held for the account of Institutional Partners II. MHR Holdings is the managing member of Fund Management. (Continued to footnote 8)
  • F8 Accordingly, Institutional Advisors II, MHRC II, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the Common Shares held for the account of Institutional Partners II. Each of Institutional Advisors II, MHRC II, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such Common Shares except to the extent of their pecuniary interest therein.
Open filing 0001193125-26-301179 Read from the filing’s XML Dispute this row
2026-07-08 Filed 2026-07-10RACHESKY MARK H MD Director · 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Shares
Disposed (D)3,701,988——0Indirect (I) See FootnotesNo
F28, F32, F33, F9, F10
  • F28 In connection with the CV Transaction, Institutional Partners IIA contributed the Common Shares held for its account to Sun IIA and LION Holdco B, in exchange for limited partnership interests in Sun IIA and limited partnership interests and certain other interests in LION Holdco B.
  • F32 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Voting and Standstill Agreement, by and among the Issuer, Liberty Global Ventures Limited, a limited company organized under the laws of England and Wales, Liberty Global Ltd., Bermuda exempted company limited by shares, Discovery Lightning Investments Ltd., a limited company organized under the laws of England and Wales, Warner Bros. Discovery, Inc., a Delaware corporation, Master Account, Capital Partners (100), Institutional Partners II, Institutional Partners IIA, Institutional Partners III, Institutional Partners IV and Fund Management, but as to which they have no pecuniary interest.
  • F33 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Governance, Standstill and Voting Agreement, by and among Fund Management and certain of its affiliates and Liberty 77 Capital L.P., a Delaware limited partnership, Liberty 77 Fund L.P., a Cayman Islands exempted limited partnership and Liberty 77 Fund International L.P., a Cayman Islands exempted limited partnership, but as to which they have no pecuniary interest.
  • F9 These Common Shares are held for the account of MHR Institutional Partners IIA LP, a Delaware limited partnership (Institutional Partners IIA). Institutional Advisors II is the general partner of Institutional Partners IIA. MHRC II is the managing member of Institutional Advisors II. Dr. Rachesky is the managing member of MHRC II. Fund Management has an investment management agreement with Institutional Partners IIA pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the Common Shares held for the account of Institutional Partners IIA. MHR Holdings is the managing member of Fund Management. (Continued to footnote 10)
  • F10 Accordingly, Institutional Advisors II, MHRC II, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the Common Shares held for the account of Institutional Partners IIA. Each of Institutional Advisors II, MHRC II, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such Common Shares except to the extent of their pecuniary interest therein.
Open filing 0001193125-26-301179 Read from the filing’s XML Dispute this row
2026-07-08 Filed 2026-07-10RACHESKY MARK H MD Director · 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Shares
Disposed (D)25,173,882——0Indirect (I) See FootnotesNo
F29, F32, F33, F11, F12
  • F29 In connection with the CV Transaction, Institutional Partners III contributed the Common Shares held for its account to Sun III and LION Holdco B, in exchange for limited partnership interests in Sun III and limited partnership interests and certain other interests in LION Holdco B.
  • F32 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Voting and Standstill Agreement, by and among the Issuer, Liberty Global Ventures Limited, a limited company organized under the laws of England and Wales, Liberty Global Ltd., Bermuda exempted company limited by shares, Discovery Lightning Investments Ltd., a limited company organized under the laws of England and Wales, Warner Bros. Discovery, Inc., a Delaware corporation, Master Account, Capital Partners (100), Institutional Partners II, Institutional Partners IIA, Institutional Partners III, Institutional Partners IV and Fund Management, but as to which they have no pecuniary interest.
  • F33 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Governance, Standstill and Voting Agreement, by and among Fund Management and certain of its affiliates and Liberty 77 Capital L.P., a Delaware limited partnership, Liberty 77 Fund L.P., a Cayman Islands exempted limited partnership and Liberty 77 Fund International L.P., a Cayman Islands exempted limited partnership, but as to which they have no pecuniary interest.
  • F11 These Common Shares are held for the account of MHR Institutional Partners III LP, a Delaware limited partnership (Institutional Partners III). MHR Institutional Advisors III LLC, a Delaware limited liability company (Institutional Advisors III), is the general partner of Institutional Partners III. Dr. Rachesky is the managing member of Institutional Advisors III. Fund Management has an investment management agreement with Institutional Partners III pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the Common Shares held for the account of Institutional Partners III. MHR Holdings is the managing member of Fund Management. (Continued to footnote 12)
  • F12 Accordingly, Institutional Advisors III, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the Common Shares held for the account of Institutional Partners III. Each of Institutional Advisors III, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such Common Shares except to the extent of their pecuniary interest therein.
Open filing 0001193125-26-301179 Read from the filing’s XML Dispute this row
2026-07-08 Filed 2026-07-10RACHESKY MARK H MD Director · 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Shares
Acquired (A)797,526——797,526Indirect (I) See FootnotesNo
F27, F32, F33, F13, F14
  • F27 In connection with that certain continuation fund transaction, as further described in Amendment No. 2 to Schedule 13D filed by the certain of the reporting persons on July 9, 2026 (the CV Transaction), Institutional Partners II contributed the Common Shares held for its account to Sun II and LION Holdco A, in exchange for limited partnership interests in Sun II and limited partnership interests and certain other interests in LION Holdco A. Dr. Rachesky's indirect pecuniary interest in the Common Shares may be deemed to have increased as a result of the transactions described in footnotes (27), (28) and (29) due to Dr. Rachesky and certain of his affiliated entities being investors in an entity that is a limited partner in LION Holdco A and LION Holdco B.
  • F32 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Voting and Standstill Agreement, by and among the Issuer, Liberty Global Ventures Limited, a limited company organized under the laws of England and Wales, Liberty Global Ltd., Bermuda exempted company limited by shares, Discovery Lightning Investments Ltd., a limited company organized under the laws of England and Wales, Warner Bros. Discovery, Inc., a Delaware corporation, Master Account, Capital Partners (100), Institutional Partners II, Institutional Partners IIA, Institutional Partners III, Institutional Partners IV and Fund Management, but as to which they have no pecuniary interest.
  • F33 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Governance, Standstill and Voting Agreement, by and among Fund Management and certain of its affiliates and Liberty 77 Capital L.P., a Delaware limited partnership, Liberty 77 Fund L.P., a Cayman Islands exempted limited partnership and Liberty 77 Fund International L.P., a Cayman Islands exempted limited partnership, but as to which they have no pecuniary interest.
  • F13 These Common Shares are held for the account of MHR Sun II LP, a Delaware limited partnership (Sun II). MHR Institutional Advisors II LLC, a Delaware limited liability company (Institutional Advisors II), is the general partner of Sun II. MHRC II is the managing member of Institutional Advisors II. Dr. Rachesky is the managing member of MHRC II. Fund Management has an investment management agreement with Sun II pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the Common Shares held for the account of Sun II. MHR Holdings is the managing member of Fund Management. (Continued to footnote 14)
  • F14 Accordingly, Institutional Advisors II, MHRC II, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the Common Shares held for the account of Sun II. Each of Institutional Advisors II, MHRC II, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such Common Shares except to the extent of their pecuniary interest therein.
Open filing 0001193125-26-301179 Read from the filing’s XML Dispute this row
2026-07-08 Filed 2026-07-10RACHESKY MARK H MD Director · 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Shares
Acquired (A)1,916,271——1,916,271Indirect (I) See FootnotesNo
F28, F32, F33, F15, F16
  • F28 In connection with the CV Transaction, Institutional Partners IIA contributed the Common Shares held for its account to Sun IIA and LION Holdco B, in exchange for limited partnership interests in Sun IIA and limited partnership interests and certain other interests in LION Holdco B.
  • F32 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Voting and Standstill Agreement, by and among the Issuer, Liberty Global Ventures Limited, a limited company organized under the laws of England and Wales, Liberty Global Ltd., Bermuda exempted company limited by shares, Discovery Lightning Investments Ltd., a limited company organized under the laws of England and Wales, Warner Bros. Discovery, Inc., a Delaware corporation, Master Account, Capital Partners (100), Institutional Partners II, Institutional Partners IIA, Institutional Partners III, Institutional Partners IV and Fund Management, but as to which they have no pecuniary interest.
  • F33 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Governance, Standstill and Voting Agreement, by and among Fund Management and certain of its affiliates and Liberty 77 Capital L.P., a Delaware limited partnership, Liberty 77 Fund L.P., a Cayman Islands exempted limited partnership and Liberty 77 Fund International L.P., a Cayman Islands exempted limited partnership, but as to which they have no pecuniary interest.
  • F15 These Common Shares are held for the account of MHR Sun IIA LP, a Delaware limited partnership (Sun IIA). Institutional Advisors II is the general partner of Sun IIA. MHRC II is the managing member of Institutional Advisors II. Dr. Rachesky is the managing member of MHRC II. Fund Management has an investment management agreement with Sun IIA pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the Common Shares held for the account of Sun IIA. MHR Holdings is the managing member of Fund Management. (Continued to footnote 16)
  • F16 Accordingly, Institutional Advisors II, MHRC II, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the Common Shares held for the account of Sun IIA. Each of Institutional Advisors II, MHRC II, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such Common Shares except to the extent of their pecuniary interest therein.
Open filing 0001193125-26-301179 Read from the filing’s XML Dispute this row
2026-07-08 Filed 2026-07-10RACHESKY MARK H MD Director · 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Shares
Acquired (A)11,154,680——11,154,680Indirect (I) See FootnotesNo
F29, F32, F33, F17, F18
  • F29 In connection with the CV Transaction, Institutional Partners III contributed the Common Shares held for its account to Sun III and LION Holdco B, in exchange for limited partnership interests in Sun III and limited partnership interests and certain other interests in LION Holdco B.
  • F32 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Voting and Standstill Agreement, by and among the Issuer, Liberty Global Ventures Limited, a limited company organized under the laws of England and Wales, Liberty Global Ltd., Bermuda exempted company limited by shares, Discovery Lightning Investments Ltd., a limited company organized under the laws of England and Wales, Warner Bros. Discovery, Inc., a Delaware corporation, Master Account, Capital Partners (100), Institutional Partners II, Institutional Partners IIA, Institutional Partners III, Institutional Partners IV and Fund Management, but as to which they have no pecuniary interest.
  • F33 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Governance, Standstill and Voting Agreement, by and among Fund Management and certain of its affiliates and Liberty 77 Capital L.P., a Delaware limited partnership, Liberty 77 Fund L.P., a Cayman Islands exempted limited partnership and Liberty 77 Fund International L.P., a Cayman Islands exempted limited partnership, but as to which they have no pecuniary interest.
  • F17 These Common Shares are held for the account of MHR Sun III LP, a Delaware limited partnership (Sun III). MHR Institutional Advisors III LLC, a Delaware limited liability company (Institutional Advisors III), is the general partner of Sun III. Dr. Rachesky is the managing member of Institutional Advisors III. Fund Management has an investment management agreement with Sun III pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the Common Shares held for the account of Sun III. MHR Holdings is the managing member of Fund Management. (Continued to footnote 18)
  • F18 Accordingly, Institutional Advisors III, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the Common Shares held for the account of Sun III. Each of Institutional Advisors III, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such Common Shares except to the extent of their pecuniary interest therein.
Open filing 0001193125-26-301179 Read from the filing’s XML Dispute this row
2026-07-08 Filed 2026-07-10RACHESKY MARK H MD Director · 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Shares
Acquired (A)671,924——671,924Indirect (I) See FootnotesNo
F27, F32, F33, F19, F20
  • F27 In connection with that certain continuation fund transaction, as further described in Amendment No. 2 to Schedule 13D filed by the certain of the reporting persons on July 9, 2026 (the CV Transaction), Institutional Partners II contributed the Common Shares held for its account to Sun II and LION Holdco A, in exchange for limited partnership interests in Sun II and limited partnership interests and certain other interests in LION Holdco A. Dr. Rachesky's indirect pecuniary interest in the Common Shares may be deemed to have increased as a result of the transactions described in footnotes (27), (28) and (29) due to Dr. Rachesky and certain of his affiliated entities being investors in an entity that is a limited partner in LION Holdco A and LION Holdco B.
  • F32 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Voting and Standstill Agreement, by and among the Issuer, Liberty Global Ventures Limited, a limited company organized under the laws of England and Wales, Liberty Global Ltd., Bermuda exempted company limited by shares, Discovery Lightning Investments Ltd., a limited company organized under the laws of England and Wales, Warner Bros. Discovery, Inc., a Delaware corporation, Master Account, Capital Partners (100), Institutional Partners II, Institutional Partners IIA, Institutional Partners III, Institutional Partners IV and Fund Management, but as to which they have no pecuniary interest.
  • F33 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Governance, Standstill and Voting Agreement, by and among Fund Management and certain of its affiliates and Liberty 77 Capital L.P., a Delaware limited partnership, Liberty 77 Fund L.P., a Cayman Islands exempted limited partnership and Liberty 77 Fund International L.P., a Cayman Islands exempted limited partnership, but as to which they have no pecuniary interest.
  • F19 These Common Shares are held for the account of MHR LION Holdco A LP, a Delaware limited partnership (LION Holdco A). MHR Sun GP LLC, a Delaware limited liability company (MHR Sun GP), is the general partner of LION Holdco A. The Rachesky Revocable Trust (the Trust) is the managing member of MHR Sun GP. Dr. Rachesky is the sole trustee of the Trust. Fund Management has an investment management agreement with LION Holdco A pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the Common Shares held for the account of LION Holdco A. MHR Holdings is the managing member of Fund Management. (Continued to footnote 20)
  • F20 Accordingly, MHR Sun GP, the Trust, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the Common Shares held for the account of LION Holdco A. Each of MHR Sun GP, the Trust, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such Common Shares except to the extent of their pecuniary interest therein.
Open filing 0001193125-26-301179 Read from the filing’s XML Dispute this row
2026-07-08 Filed 2026-07-10RACHESKY MARK H MD Director · 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Shares
Disposed (D)499,765——172,159Indirect (I) See FootnotesNo
F30, F32, F33, F19, F20
  • F30 In further connection with the CV Transaction, immediately following the contribution of Common Shares from Institutional Partners II, LION Holdco A, as the sole limited partner of LION SubHoldco A, contributed certain of the Common Shares held for its account to LION SubHoldco A.
  • F32 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Voting and Standstill Agreement, by and among the Issuer, Liberty Global Ventures Limited, a limited company organized under the laws of England and Wales, Liberty Global Ltd., Bermuda exempted company limited by shares, Discovery Lightning Investments Ltd., a limited company organized under the laws of England and Wales, Warner Bros. Discovery, Inc., a Delaware corporation, Master Account, Capital Partners (100), Institutional Partners II, Institutional Partners IIA, Institutional Partners III, Institutional Partners IV and Fund Management, but as to which they have no pecuniary interest.
  • F33 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Governance, Standstill and Voting Agreement, by and among Fund Management and certain of its affiliates and Liberty 77 Capital L.P., a Delaware limited partnership, Liberty 77 Fund L.P., a Cayman Islands exempted limited partnership and Liberty 77 Fund International L.P., a Cayman Islands exempted limited partnership, but as to which they have no pecuniary interest.
  • F19 These Common Shares are held for the account of MHR LION Holdco A LP, a Delaware limited partnership (LION Holdco A). MHR Sun GP LLC, a Delaware limited liability company (MHR Sun GP), is the general partner of LION Holdco A. The Rachesky Revocable Trust (the Trust) is the managing member of MHR Sun GP. Dr. Rachesky is the sole trustee of the Trust. Fund Management has an investment management agreement with LION Holdco A pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the Common Shares held for the account of LION Holdco A. MHR Holdings is the managing member of Fund Management. (Continued to footnote 20)
  • F20 Accordingly, MHR Sun GP, the Trust, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the Common Shares held for the account of LION Holdco A. Each of MHR Sun GP, the Trust, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such Common Shares except to the extent of their pecuniary interest therein.
Open filing 0001193125-26-301179 Read from the filing’s XML Dispute this row
2026-07-08 Filed 2026-07-10RACHESKY MARK H MD Director · 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Shares
Acquired (A)499,765——499,765Indirect (I) See FootnotesNo
F30, F32, F33, F21, F22
  • F30 In further connection with the CV Transaction, immediately following the contribution of Common Shares from Institutional Partners II, LION Holdco A, as the sole limited partner of LION SubHoldco A, contributed certain of the Common Shares held for its account to LION SubHoldco A.
  • F32 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Voting and Standstill Agreement, by and among the Issuer, Liberty Global Ventures Limited, a limited company organized under the laws of England and Wales, Liberty Global Ltd., Bermuda exempted company limited by shares, Discovery Lightning Investments Ltd., a limited company organized under the laws of England and Wales, Warner Bros. Discovery, Inc., a Delaware corporation, Master Account, Capital Partners (100), Institutional Partners II, Institutional Partners IIA, Institutional Partners III, Institutional Partners IV and Fund Management, but as to which they have no pecuniary interest.
  • F33 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Governance, Standstill and Voting Agreement, by and among Fund Management and certain of its affiliates and Liberty 77 Capital L.P., a Delaware limited partnership, Liberty 77 Fund L.P., a Cayman Islands exempted limited partnership and Liberty 77 Fund International L.P., a Cayman Islands exempted limited partnership, but as to which they have no pecuniary interest.
  • F21 These Common Shares are held for the account of MHR LION SubHoldco A LP, a Delaware limited partnership (LION SubHoldco A). MHR Sun GP is the general partner of LION SubHoldco A. The Trust is the managing member of MHR Sun GP. Dr. Rachesky is the sole trustee of the Trust. Fund Management has an investment management agreement with LION SubHoldco A pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the Common Shares held for the account of LION SubHoldco A. MHR Holdings is the managing member of Fund Management. (Continued to footnote 22)
  • F22 Accordingly, MHR Sun GP, the Trust, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the Common Shares held for the account of LION SubHoldco A. Each of MHR Sun GP, the Trust, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such Common Shares except to the extent of their pecuniary interest therein.
Open filing 0001193125-26-301179 Read from the filing’s XML Dispute this row
2026-07-08 Filed 2026-07-10RACHESKY MARK H MD Director · 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Shares
Acquired (A)15,804,919——15,804,919Indirect (I) See FootnotesNo
F28, F29, F32, F33, F23, F24
  • F28 In connection with the CV Transaction, Institutional Partners IIA contributed the Common Shares held for its account to Sun IIA and LION Holdco B, in exchange for limited partnership interests in Sun IIA and limited partnership interests and certain other interests in LION Holdco B.
  • F29 In connection with the CV Transaction, Institutional Partners III contributed the Common Shares held for its account to Sun III and LION Holdco B, in exchange for limited partnership interests in Sun III and limited partnership interests and certain other interests in LION Holdco B.
  • F32 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Voting and Standstill Agreement, by and among the Issuer, Liberty Global Ventures Limited, a limited company organized under the laws of England and Wales, Liberty Global Ltd., Bermuda exempted company limited by shares, Discovery Lightning Investments Ltd., a limited company organized under the laws of England and Wales, Warner Bros. Discovery, Inc., a Delaware corporation, Master Account, Capital Partners (100), Institutional Partners II, Institutional Partners IIA, Institutional Partners III, Institutional Partners IV and Fund Management, but as to which they have no pecuniary interest.
  • F33 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Governance, Standstill and Voting Agreement, by and among Fund Management and certain of its affiliates and Liberty 77 Capital L.P., a Delaware limited partnership, Liberty 77 Fund L.P., a Cayman Islands exempted limited partnership and Liberty 77 Fund International L.P., a Cayman Islands exempted limited partnership, but as to which they have no pecuniary interest.
  • F23 These Common Shares are held for the account of MHR LION Holdco B LP, a Delaware limited partnership (LION Holdco B). MHR Sun GP is the general partner of LION Holdco B. The Trust is the managing member of MHR Sun GP. Dr. Rachesky is the sole trustee of the Trust. Fund Management has an investment management agreement with LION Holdco B pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the Common Shares held for the account of LION Holdco B. MHR Holdings is the managing member of Fund Management. (Continued to footnote 24)
  • F24 Accordingly, MHR Sun GP, the Trust, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the Common Shares held for the account of LION Holdco B. Each of MHR Sun GP, the Trust, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such Common Shares except to the extent of their pecuniary interest therein.
Open filing 0001193125-26-301179 Read from the filing’s XML Dispute this row
2026-07-08 Filed 2026-07-10RACHESKY MARK H MD Director · 10% owner
S

Open market or private sale of non-derivative or derivative security

Common Shares
Disposed (D)11,755,412——4,049,507Indirect (I) See FootnotesNo
F31, F32, F33, F23, F24
  • F31 In connection with the CV Transaction, immediately following the contribution of Common Shares from Institutional Partners IIA and Institutional Partners III, LION Holdco B, as the sole limited partner of LION SubHoldco B, contributed certain of the Common Shares held for its account to LION SubHoldco B.
  • F32 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Voting and Standstill Agreement, by and among the Issuer, Liberty Global Ventures Limited, a limited company organized under the laws of England and Wales, Liberty Global Ltd., Bermuda exempted company limited by shares, Discovery Lightning Investments Ltd., a limited company organized under the laws of England and Wales, Warner Bros. Discovery, Inc., a Delaware corporation, Master Account, Capital Partners (100), Institutional Partners II, Institutional Partners IIA, Institutional Partners III, Institutional Partners IV and Fund Management, but as to which they have no pecuniary interest.
  • F33 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Governance, Standstill and Voting Agreement, by and among Fund Management and certain of its affiliates and Liberty 77 Capital L.P., a Delaware limited partnership, Liberty 77 Fund L.P., a Cayman Islands exempted limited partnership and Liberty 77 Fund International L.P., a Cayman Islands exempted limited partnership, but as to which they have no pecuniary interest.
  • F23 These Common Shares are held for the account of MHR LION Holdco B LP, a Delaware limited partnership (LION Holdco B). MHR Sun GP is the general partner of LION Holdco B. The Trust is the managing member of MHR Sun GP. Dr. Rachesky is the sole trustee of the Trust. Fund Management has an investment management agreement with LION Holdco B pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the Common Shares held for the account of LION Holdco B. MHR Holdings is the managing member of Fund Management. (Continued to footnote 24)
  • F24 Accordingly, MHR Sun GP, the Trust, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the Common Shares held for the account of LION Holdco B. Each of MHR Sun GP, the Trust, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such Common Shares except to the extent of their pecuniary interest therein.
Open filing 0001193125-26-301179 Read from the filing’s XML Dispute this row
2026-07-08 Filed 2026-07-10RACHESKY MARK H MD Director · 10% owner
P

Open market or private purchase of non-derivative or derivative security

Common Shares
Acquired (A)11,755,412——11,755,412Indirect (I) See FootnotesNo
F31, F32, F33, F25, F26
  • F31 In connection with the CV Transaction, immediately following the contribution of Common Shares from Institutional Partners IIA and Institutional Partners III, LION Holdco B, as the sole limited partner of LION SubHoldco B, contributed certain of the Common Shares held for its account to LION SubHoldco B.
  • F32 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Voting and Standstill Agreement, by and among the Issuer, Liberty Global Ventures Limited, a limited company organized under the laws of England and Wales, Liberty Global Ltd., Bermuda exempted company limited by shares, Discovery Lightning Investments Ltd., a limited company organized under the laws of England and Wales, Warner Bros. Discovery, Inc., a Delaware corporation, Master Account, Capital Partners (100), Institutional Partners II, Institutional Partners IIA, Institutional Partners III, Institutional Partners IV and Fund Management, but as to which they have no pecuniary interest.
  • F33 The Common Shares reported as owned on this Form 4 do not include the Common Shares, which the reporting persons may be deemed to beneficially own as a result of that certain Governance, Standstill and Voting Agreement, by and among Fund Management and certain of its affiliates and Liberty 77 Capital L.P., a Delaware limited partnership, Liberty 77 Fund L.P., a Cayman Islands exempted limited partnership and Liberty 77 Fund International L.P., a Cayman Islands exempted limited partnership, but as to which they have no pecuniary interest.
  • F25 These Common Shares are held for the account of MHR LION SubHoldco B LP, a Delaware limited partnership (LION SubHoldco B). MHR Sun GP is the general partner of LION SubHoldco B. The Trust is the managing mamber of MHR Sun GP. Dr. Rachesky is the sole trustee of the Trust. Fund Management has an investment management agreement with LION SubHoldco B pursuant to which it has the power to vote or direct the vote and to dispose or to direct the disposition of the Common Shares held for the account of LION SubHoldco B. MHR Holdings is the managing member of Fund Management. (Continued to footnote 26)
  • F26 Accordingly, MHR Sun GP, the Trust, Fund Management, MHR Holdings and Dr. Rachesky may be deemed to beneficially own the Common Shares held for the account of LION SubHoldco B. Each of MHR Sun GP, the Trust, Fund Management, MHR Holdings and Dr. Rachesky disclaims beneficial ownership of such Common Shares except to the extent of their pecuniary interest therein.
Open filing 0001193125-26-301179 Read from the filing’s XML Dispute this row
2026-07-03 Filed 2026-07-10FELTHEIMER JON Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Shares
Disposed (D)103,66914.66
1,519,787.54

Derived: shares × price per share. Exact value 1519787.54.

4,290,776Direct (D) No
F1, F2
  • F1 This amendment is being filed to reflect that 103,669 common shares, rather than 196,902 common shares, were automatically canceled to satisfy certain of the reporting person's tax withholding obligations upon the vesting of 196,902 restricted share units (RSUs). The remaining line items reported herein are included solely to update the reporting person's post-transaction holdings resulting from such adjustment.
  • F2 Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 175,798 RSUs scheduled to vest on July 1, 2027; (ii) 487,664 RSUs scheduled to vest in two equal annual installments on July 1, 2027 and 2028; and (iii) 632,069 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001254386-26-000004 Read from the filing’s XML Dispute this row
2026-07-03 Filed 2026-07-10FELTHEIMER JON Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)196,9020—4,487,678Direct (D) No
F3, F2
  • F3 Represents common shares issued upon the vesting of performance RSUs granted pursuant to the terms of an employment agreement.
  • F2 Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 175,798 RSUs scheduled to vest on July 1, 2027; (ii) 487,664 RSUs scheduled to vest in two equal annual installments on July 1, 2027 and 2028; and (iii) 632,069 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001254386-26-000004 Read from the filing’s XML Dispute this row
2026-07-03 Filed 2026-07-10FELTHEIMER JON Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Shares
Disposed (D)103,66914.66
1,519,787.54

Derived: shares × price per share. Exact value 1519787.54.

4,384,009Direct (D) No
F4, F2
  • F4 Represents common shares withheld by the Issuer to satisfy certain tax withholding obligations upon the vesting of 196,902 performance RSUs. The grant of the units is reported herein and, pursuant to the Lionsgate Studios Corp. 2025 Performance Incentive Plan and the Issuer's policies, 103,669 common shares were automatically canceled to cover certain of the reporting person's tax obligations.
  • F2 Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 175,798 RSUs scheduled to vest on July 1, 2027; (ii) 487,664 RSUs scheduled to vest in two equal annual installments on July 1, 2027 and 2028; and (iii) 632,069 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001254386-26-000004 Read from the filing’s XML Dispute this row
2026-07-03 Filed 2026-07-06FELTHEIMER JON Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Shares
Disposed (D)196,90214.66
2,886,583.32

Derived: shares × price per share. Exact value 2886583.32.

4,197,543Direct (D) No
F10, F11
  • F10 Represents common shares withheld by the Issuer to satisfy certain tax withholding obligations upon the vesting of 196,902 RSUs. The grant of the units was previously reported and, pursuant to the Lionsgate Studios Corp. 2025 Performance Incentive Plan and the Issuer's policies, 103,669 common shares were automatically canceled to cover certain of the reporting person's tax obligations.
  • F11 Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 175,798 RSUs scheduled to vest on July 1, 2027; (ii) 487,664 RSUs scheduled to vest in two equal annual installments on July 1, 2027 and 2028; and (iii) 632,069 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001254386-26-000002 Read from the filing’s XML Dispute this row
2026-07-03 Filed 2026-07-06FELTHEIMER JON Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)196,9020—4,394,445Direct (D) No
F5, F11
  • F5 Represents common shares issued upon the vesting of performance RSUs granted pursuant to the terms of an employment agreement.
  • F11 Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 175,798 RSUs scheduled to vest on July 1, 2027; (ii) 487,664 RSUs scheduled to vest in two equal annual installments on July 1, 2027 and 2028; and (iii) 632,069 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001254386-26-000002 Read from the filing’s XML Dispute this row
2026-07-03 Filed 2026-07-06FELTHEIMER JON Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Shares
Disposed (D)103,66914.66
1,519,787.54

Derived: shares × price per share. Exact value 1519787.54.

4,290,776Direct (D) No
F12, F11
  • F12 Represents common shares withheld by the Issuer to satisfy certain tax withholding obligations upon the vesting of 196,902 performance RSUs. The grant of the units is reported herein and, pursuant to the Lionsgate Studios Corp. 2025 Performance Incentive Plan and the Issuer's policies, 103,669 common shares were automatically canceled to cover certain of the reporting person's tax obligations.
  • F11 Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 175,798 RSUs scheduled to vest on July 1, 2027; (ii) 487,664 RSUs scheduled to vest in two equal annual installments on July 1, 2027 and 2028; and (iii) 632,069 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001254386-26-000002 Read from the filing’s XML Dispute this row
2026-07-03 Filed 2026-07-06BURNS MICHAEL RAYMOND Officer: Vice Chair
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Shares
Disposed (D)35,06414.66
514,038.24

Derived: shares × price per share. Exact value 514038.24.

3,218,545Direct (D) No
F10, F11
  • F10 Represents common shares withheld by the Issuer to satisfy certain tax withholding obligations upon the vesting of 68,916 RSUs. The grant of the units was previously reported and, pursuant to the Lionsgate Studios Corp. 2025 Performance Incentive Plan and the Issuer's policies, 35,064 common shares were automatically canceled to cover certain of the reporting person's tax obligations.
  • F11 Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 105,479 RSUs scheduled to vest on July 1, 2027; (ii) 24,383 RSUs scheduled to vest in two equal annual installments on July 1, 2027 and 2028; and (iii) 133,067 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001254639-26-000003 Read from the filing’s XML Dispute this row
2026-07-03 Filed 2026-07-06BURNS MICHAEL RAYMOND Officer: Vice Chair
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)68,9260—3,287,471Direct (D) No
F5, F11
  • F5 Represents common shares issued upon the vesting of performance RSUs granted pursuant to the terms of an employment agreement.
  • F11 Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 105,479 RSUs scheduled to vest on July 1, 2027; (ii) 24,383 RSUs scheduled to vest in two equal annual installments on July 1, 2027 and 2028; and (iii) 133,067 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001254639-26-000003 Read from the filing’s XML Dispute this row
2026-07-03 Filed 2026-07-06BURNS MICHAEL RAYMOND Officer: Vice Chair
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Shares
Disposed (D)35,06414.66
514,038.24

Derived: shares × price per share. Exact value 514038.24.

3,252,407Direct (D) No
F12, F11
  • F12 Represents common shares withheld by the Issuer to satisfy certain tax withholding obligations upon the vesting of 68,916 performance RSUs. The grant of the units is reported herein and, pursuant to the Lionsgate Studios Corp. 2025 Performance Incentive Plan and the Issuer's policies, 35,064 common shares were automatically canceled to cover certain of the reporting person's tax obligations.
  • F11 Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 105,479 RSUs scheduled to vest on July 1, 2027; (ii) 24,383 RSUs scheduled to vest in two equal annual installments on July 1, 2027 and 2028; and (iii) 133,067 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001254639-26-000003 Read from the filing’s XML Dispute this row
2026-07-03 Filed 2026-07-06Goldsmith Brian Officer: Chief Operating Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Shares
Disposed (D)35,06414.66
514,038.24

Derived: shares × price per share. Exact value 514038.24.

1,700,030Direct (D) No
F10, F11
  • F10 Represents common shares withheld by the Issuer to satisfy certain tax withholding obligations upon the vesting of 68,916 RSUs. The grant of the units was previously reported and, pursuant to the Lionsgate Studios Corp. 2025 Performance Incentive Plan and the Issuer's policies, 35,064 common shares were automatically canceled to cover certain of the reporting person's tax obligations.
  • F11 Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 61,529 RSUs scheduled to vest on July 1, 2027; (ii) 170,682 RSUs scheduled to vest in two equal annual installments on July 1, 2027 and 2028; and (iii) 221,224 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001558979-26-000003 Read from the filing’s XML Dispute this row
2026-07-03 Filed 2026-07-06Goldsmith Brian Officer: Chief Operating Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)68,9160—1,768,946Direct (D) No
F5, F11
  • F5 Represents common shares issued upon the vesting of performance RSUs granted pursuant to the terms of an employment agreement.
  • F11 Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 61,529 RSUs scheduled to vest on July 1, 2027; (ii) 170,682 RSUs scheduled to vest in two equal annual installments on July 1, 2027 and 2028; and (iii) 221,224 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001558979-26-000003 Read from the filing’s XML Dispute this row
2026-07-03 Filed 2026-07-06Goldsmith Brian Officer: Chief Operating Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Shares
Disposed (D)35,06414.66
514,038.24

Derived: shares × price per share. Exact value 514038.24.

1,733,882Direct (D) No
F12, F11
  • F12 Represents common shares withheld by the Issuer to satisfy certain tax withholding obligations upon the vesting of 68,916 performance RSUs. The grant of the units is reported herein and, pursuant to the Lionsgate Studios Corp. 2025 Performance Incentive Plan and the Issuer's policies, 35,064 common shares were automatically canceled to cover certain of the reporting person's tax obligations.
  • F11 Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 61,529 RSUs scheduled to vest on July 1, 2027; (ii) 170,682 RSUs scheduled to vest in two equal annual installments on July 1, 2027 and 2028; and (iii) 221,224 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001558979-26-000003 Read from the filing’s XML Dispute this row
2026-07-03 Filed 2026-07-06Tobey Bruce Officer: General Counsel
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Shares
Disposed (D)10,01814.66
146,863.88

Derived: shares × price per share. Exact value 146863.88.

411,811Direct (D) No
F10, F11
  • F10 Represents common shares withheld by the Issuer to satisfy certain tax withholding obligations upon the vesting of 19,690 RSUs. The grant of the units was previously reported and, pursuant to the Lionsgate Studios Corp. 2025 Performance Incentive Plan and the Issuer's policies, 10,018 common shares were automatically canceled to cover certain of the reporting person's tax obligations.
  • F11 Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 22,853 RSUs scheduled to vest on July 1, 2027; (ii) 45,742 RSUs scheduled to vest in two equal annual installments on April 9, 2027 and 2028; (iii) 58,520 RSUs scheduled to vest in two equal annual installments on July 1, 2027 and 2028; and (iv) 75,848 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001971761-26-000004 Read from the filing’s XML Dispute this row
2026-07-03 Filed 2026-07-06Tobey Bruce Officer: General Counsel
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)19,6900—431,501Direct (D) No
F5, F11
  • F5 Represents common shares issued upon the vesting of performance RSUs granted pursuant to the terms of an employment agreement.
  • F11 Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 22,853 RSUs scheduled to vest on July 1, 2027; (ii) 45,742 RSUs scheduled to vest in two equal annual installments on April 9, 2027 and 2028; (iii) 58,520 RSUs scheduled to vest in two equal annual installments on July 1, 2027 and 2028; and (iv) 75,848 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001971761-26-000004 Read from the filing’s XML Dispute this row
2026-07-03 Filed 2026-07-06Tobey Bruce Officer: General Counsel
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Shares
Disposed (D)10,01814.66
146,863.88

Derived: shares × price per share. Exact value 146863.88.

421,483Direct (D) No
F12, F11
  • F12 Represents common shares withheld by the Issuer to satisfy certain tax withholding obligations upon the vesting of 19,690 performance RSUs. The grant of the units is reported herein and, pursuant to the Lionsgate Studios Corp. 2025 Performance Incentive Plan and the Issuer's policies, 10,018 common shares were automatically canceled to cover certain of the reporting person's tax obligations.
  • F11 Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 22,853 RSUs scheduled to vest on July 1, 2027; (ii) 45,742 RSUs scheduled to vest in two equal annual installments on April 9, 2027 and 2028; (iii) 58,520 RSUs scheduled to vest in two equal annual installments on July 1, 2027 and 2028; and (iv) 75,848 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001971761-26-000004 Read from the filing’s XML Dispute this row
2026-07-03 Filed 2026-07-06BARGE JAMES W Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Shares
Disposed (D)32,56014.66
477,329.6

Derived: shares × price per share. Exact value 477329.60.

1,893,634Direct (D) No
F10, F11
  • F10 Represents common shares withheld by the Issuer to satisfy certain tax withholding obligations upon the vesting of 63,993 RSUs. The grant of the units was previously reported and, pursuant to the Lionsgate Studios Corp. 2025 Performance Incentive Plan and the Issuer's policies, 32,560 common shares were automatically canceled to cover certain of the reporting person's tax obligations.
  • F11 Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 65,924 RSUs scheduled to vest on July 1, 2027; (ii) 182,874 RSUs scheduled to vest in two equal annual installments on July 1, 2027 and 2028; and (iii) 237,026 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001237441-26-000002 Read from the filing’s XML Dispute this row
2026-07-03 Filed 2026-07-06BARGE JAMES W Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)63,9930—1,957,627Direct (D) No
F5, F11
  • F5 Represents common shares issued upon the vesting of performance RSUs granted pursuant to the terms of an employment agreement.
  • F11 Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 65,924 RSUs scheduled to vest on July 1, 2027; (ii) 182,874 RSUs scheduled to vest in two equal annual installments on July 1, 2027 and 2028; and (iii) 237,026 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001237441-26-000002 Read from the filing’s XML Dispute this row
2026-07-03 Filed 2026-07-06BARGE JAMES W Officer: Chief Financial Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Shares
Disposed (D)32,56014.66
477,329.6

Derived: shares × price per share. Exact value 477329.60.

1,925,067Direct (D) No
F12, F11
  • F12 Represents common shares withheld by the Issuer to satisfy certain tax withholding obligations upon the vesting of 63,993 performance RSUs. The grant of the units is reported herein and, pursuant to the Lionsgate Studios Corp. 2025 Performance Incentive Plan and the Issuer's policies, 32,560 common shares were automatically canceled to cover certain of the reporting person's tax obligations.
  • F11 Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 65,924 RSUs scheduled to vest on July 1, 2027; (ii) 182,874 RSUs scheduled to vest in two equal annual installments on July 1, 2027 and 2028; and (iii) 237,026 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001237441-26-000002 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-06FELTHEIMER JON Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)632,0690—4,416,685Direct (D) No
F1, F2
  • F1 Represents an annual equity award at 95% of target, granted pursuant to the terms of an employment agreement with the reporting person.
  • F2 Amount includes the following restricted share units (RSUs) granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 196,903 RSUs scheduled to vest on July 3, 2026; (ii) 351,597 RSUs scheduled to vest in two equal annual installments on July 1, 2026 and 2027; (iii) 731,497 RSUs scheduled to vest in three equal annual installments on July 1, 2026, 2027 and 2028; and (iv) 632,069 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001254386-26-000002 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-06FELTHEIMER JON Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Shares
Disposed (D)92,55815.31
1,417,062.98

Derived: shares × price per share. Exact value 1417062.98.

4,324,127Direct (D) No
F3, F4
  • F3 Represents common shares withheld by the Issuer to satisfy certain tax withholding obligations upon the vesting of 175,799 RSUs. The grant of the units was previously reported and, pursuant to the Lionsgate Studios Corp. 2025 Performance Incentive Plan and the Issuer's policies, 92,558 common shares were automatically canceled to cover certain of the reporting person's tax obligations.
  • F4 Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 196,903 RSUs scheduled to vest on July 3, 2026; (ii) 175,798 RSUs scheduled to vest on July 1, 2027; (iii) 731,497 RSUs scheduled to vest in three equal annual installments on July 1, 2026, 2027 and 2028; and (iv) 632,069 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001254386-26-000002 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-06FELTHEIMER JON Director · Officer: Chief Executive Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Shares
Acquired (A)175,7990—4,499,926Direct (D) No
F5, F4
  • F5 Represents common shares issued upon the vesting of performance RSUs granted pursuant to the terms of an employment agreement.
  • F4 Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 196,903 RSUs scheduled to vest on July 3, 2026; (ii) 175,798 RSUs scheduled to vest on July 1, 2027; (iii) 731,497 RSUs scheduled to vest in three equal annual installments on July 1, 2026, 2027 and 2028; and (iv) 632,069 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001254386-26-000002 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-06FELTHEIMER JON Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Shares
Disposed (D)92,55815.03
1,391,146.74

Derived: shares × price per share. Exact value 1391146.74.

4,407,368Direct (D) No
F6, F4
  • F6 Represents common shares withheld by the Issuer to satisfy certain tax withholding obligations upon the vesting of 175,799 performance RSUs. The grant of the units is reported herein and, pursuant to the Lionsgate Studios Corp. 2025 Performance Incentive Plan and the Issuer's policies, 92,558 common shares were automatically canceled to cover certain of the reporting person's tax obligations.
  • F4 Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 196,903 RSUs scheduled to vest on July 3, 2026; (ii) 175,798 RSUs scheduled to vest on July 1, 2027; (iii) 731,497 RSUs scheduled to vest in three equal annual installments on July 1, 2026, 2027 and 2028; and (iv) 632,069 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001254386-26-000002 Read from the filing’s XML Dispute this row
2026-07-01 Filed 2026-07-06FELTHEIMER JON Director · Officer: Chief Executive Officer
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Shares
Disposed (D)128,37815.31
1,965,467.18

Derived: shares × price per share. Exact value 1965467.18.

4,278,990Direct (D) No
F7, F8
  • F7 Represents common shares withheld by the Issuer to satisfy certain tax withholding obligations upon the vesting of 243,833 RSUs. The grant of the units was previously reported and, pursuant to the Lionsgate Studios Corp. 2025 Performance Incentive Plan and the Issuer's policies, 128,378 common shares were automatically canceled to cover certain of the reporting person's tax obligations.
  • F8 Amount includes the following RSUs granted by the Issuer, payable upon vesting in an equal number of common shares of the Issuer: (i) 196,903 RSUs scheduled to vest on July 3, 2026; (ii) 175,798 RSUs scheduled to vest on July 1, 2027; (iii) 487,664 RSUs scheduled to vest in two equal annual installments on July 1, 2027 and 2028; and (iv) 632,069 RSUs scheduled to vest in three equal annual installments on July 1, 2027, 2028 and 2029.
Open filing 0001254386-26-000002 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,176 filings read.

Showing 1–50 of 333

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
MHR FUND MANAGEMENT LLC 37,648,498 SH421,663,178 dollarsUnchanged Prior quarter: 37,648,498Open filing 0001011438-26-000728 Filed 2026-11-16 Dispute this row
Liberty 77 Capital L.P. 37,548,125 SH420,539,000 dollarsUnchanged Prior quarter: 37,548,125Open filing 0001172661-26-005101 Filed 2026-11-16 Dispute this row
BlackRock, Inc. Partly reported under another manager16,412,483 SH183,819,809 dollarsLower by 16,087 Prior quarter: 16,428,570Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
AMERIPRISE FINANCIAL INC Partly reported under another manager13,104,631 SH146,771,888 dollarsHigher by 4,331,283 Prior quarter: 8,773,348Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 10,316,605 SH115,545,976 dollarsLower by 5,813 Prior quarter: 10,322,418Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
NEUBERGER BERMAN GROUP LLC 10,011,874 SH112,130,313 dollarsLower by 259,512 Prior quarter: 10,271,386Open filing 0001465109-26-000128 Filed 2026-11-13 Dispute this row
WELLINGTON MANAGEMENT GROUP LLP Partly reported under another manager9,537,002 SH106,814,422 dollarsHigher by 2,111,566 Prior quarter: 7,425,436Open filing 0000902219-26-000323 Filed 2026-11-16 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 9,063,029 SH101,505,925 dollarsLower by 238,006 Prior quarter: 9,301,035Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
FMR LLC Partly reported under another manager7,925,497 SH88,765,565 dollarsLower by 2,422,398 Prior quarter: 10,347,895Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
Coastal Bridge Advisors, LLC 6,440,222 SH72,130,484 dollarsHigher by 1,009,516 Prior quarter: 5,430,706Open filing 0002085853-26-001409 Filed 2026-11-18 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager6,073,029 SH68,029,025 dollarsLower by 11,591 Prior quarter: 6,084,620Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
Anson Funds Management LP 6,039,609 SH67,643,621 dollarsHigher by 1,714,609 Prior quarter: 4,325,000Open filing 0001193125-26-460605 Filed 2026-11-13 Dispute this row
Jefferies Financial Group Inc. Partly reported under another manager5,805,850 SH65,025,520 dollarsLower by 567 Prior quarter: 5,806,417Open filing 0000096223-26-000034 Filed 2026-11-05 Dispute this row
Broad Bay Capital Management, LP 5,302,665 SH59,389,848 dollarsHigher by 1,207,157 Prior quarter: 4,095,508Open filing 0001172661-26-005132 Filed 2026-11-16 Dispute this row
STATE STREET CORP Partly reported under another manager4,868,354 SH54,525,565 dollarsLower by 83,350 Prior quarter: 4,951,704Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
SHAPIRO CAPITAL MANAGEMENT LLC 4,768,325 SH53,405,241 dollarsLower by 261,680 Prior quarter: 5,030,005Open filing 0001376474-26-000713 Filed 2026-11-12 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager3,012,481 SH33,739,791 dollarsHigher by 108,759 Prior quarter: 2,903,722Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
MILLENNIUM MANAGEMENT LLC 2,965,553 SH33,214,194 dollarsHigher by 2,459,355 Prior quarter: 506,198Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
COOPER CREEK PARTNERS MANAGEMENT LLC Partly reported under another manager2,673,621 SH29,945 dollarsHigher by 625,220 Prior quarter: 2,048,401Open filing 0001512162-26-000028 Filed 2026-11-16 Dispute this row
Point72 Asset Management, L.P. 2,458,640 SH27,536,768 dollarsHigher by 2,350,477 Prior quarter: 108,163Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row
Capital World Investors Partly reported under another manager2,454,045 SH27,485,304 dollarsUnchanged Prior quarter: 2,454,045Open filing 0001422849-26-000169 Filed 2026-11-12 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager2,318,356 SH25,965,512 dollarsLower by 2,229 Prior quarter: 2,320,585Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 2,307,468 SH25,843,642 dollarsHigher by 140,065 Prior quarter: 2,167,403Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
MORGAN STANLEY Partly reported under another manager2,106,148 SH23,588,863 dollarsLower by 490,651 Prior quarter: 2,596,799Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
UBS Group AG Partly reported under another manager2,032,459 SH22,763,541 dollarsHigher by 1,237,027 Prior quarter: 795,432Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
MASTERS CAPITAL MANAGEMENT LLC 1,994,814 SH22,341,917 dollarsUnchanged Prior quarter: 1,994,814Open filing 0001104186-26-000008 Filed 2026-11-16 Dispute this row
Contour Asset Management LLC Partly reported under another manager1,891,380 SH21,183,456 dollarsNot in the prior quarter’s filings read Open filing 0001172661-26-005328 Filed 2026-11-16 Dispute this row
ROYCE ASSOCIATES LP 1,834,383 SH20,545,090 dollarsLower by 31,310 Prior quarter: 1,865,693Open filing 0000906304-26-000218 Filed 2026-11-09 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager1,824,937 SH20,439,293 dollarsHigher by 52,487 Prior quarter: 1,772,450Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
MAPLELANE CAPITAL, LLC Partly reported under another manager1,725,000 SH19,319,999 dollarsLower by 180,800 Prior quarter: 1,905,800Open filing 0000919574-26-007895 Filed 2026-11-16 Dispute this row
J. Goldman Co LP 1,630,252 SH18,258,822 dollarsNot in the prior quarter’s filings read Open filing 0001412741-26-000004 Filed 2026-11-16 Dispute this row
Janus Henderson Group Ltd. Partly reported under another manager1,568,338 SH17,566,833 dollarsNot in the prior quarter’s filings read Open filing 0001085146-26-000952 Filed 2026-11-16 Dispute this row
VANGUARD FIDUCIARY TRUST CO 1,480,657 SH16,583,358 dollarsLower by 115,333 Prior quarter: 1,595,990Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
Qube Research Technologies Ltd 1,396,132 SH15,636,678 dollarsHigher by 486,847 Prior quarter: 909,285Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row
Kite Lake Capital Management (UK) LLP 1,360,000 SH15,232,000 dollarsNot in the prior quarter’s filings read Open filing 0000919574-26-008072 Filed 2026-11-16 Dispute this row
MANE GLOBAL CAPITAL MANAGEMENT LP 1,177,889 SH13,192,357 dollarsHigher by 177,889 Prior quarter: 1,000,000Open filing 0000902664-26-004558 Filed 2026-11-16 Dispute this row
Anson Funds Management LP Option: Call 1,080,000 SH12,096,000 dollarsHigher by 80,000 Prior quarter: 1,000,000Open filing 0001193125-26-460605 Filed 2026-11-13 Dispute this row
Shannon River Fund Management LLC 1,046,129 SH11,716,645 dollarsLower by 4,316 Prior quarter: 1,050,445Open filing 0001013594-26-001175 Filed 2026-11-13 Dispute this row
Woodline Partners LP 1,036,511 SH11,608,923 dollarsLower by 3,398 Prior quarter: 1,039,909Open filing 0001172661-26-005063 Filed 2026-11-16 Dispute this row
Invesco Ltd. Partly reported under another manager1,028,524 SH11,519,469 dollarsHigher by 427,873 Prior quarter: 600,651Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
KORNITZER CAPITAL MANAGEMENT INC /KS 1,019,006 SH11,412,867 dollarsLower by 16,450 Prior quarter: 1,035,456Open filing 0000898358-26-000011 Filed 2026-11-03 Dispute this row
Nuveen, LLC Partly reported under another manager989,135 SH10,886,688 dollarsHigher by 219,580 Prior quarter: 769,555Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager940,662 SH10,535,410 dollarsLower by 32,699 Prior quarter: 973,361Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager870,172 SH9,745,926 dollarsHigher by 399,007 Prior quarter: 471,165Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
Ratan Capital Management LP Partly reported under another manager825,592 SH9,246,630 dollarsHigher by 89,722 Prior quarter: 735,870Open filing 0001566887-26-000005 Filed 2026-11-16 Dispute this row
Bayberry Capital Partners LP 818,800 SH9,170,560 dollarsHigher by 98,800 Prior quarter: 720,000Open filing 0001892688-26-000172 Filed 2026-11-16 Dispute this row
GABELLI FUNDS LLC 798,600 SH8,944,320 dollarsHigher by 65,000 Prior quarter: 733,600Open filing 0001140361-26-043450 Filed 2026-11-12 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager793,810 SH9,010,502 dollarsLower by 20,280 Prior quarter: 814,090Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
Jain Global LLC 793,384 SH8,885,901 dollarsHigher by 569,814 Prior quarter: 223,570Open filing 0000902664-26-004590 Filed 2026-11-16 Dispute this row
MAPLELANE CAPITAL, LLC Option: Call Partly reported under another manager772,500 SH8,652,000 dollarsHigher by 372,500 Prior quarter: 400,000Open filing 0000919574-26-007895 Filed 2026-11-16 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Jericho Capital Asset Management L.P. 18,815,105 SH
  • Sixth Street Partners Management Company, L.P. 2,167,403 SH
  • Avala Global LP 1,786,857 SH
  • ThornTree Capital Partners LP 1,246,584 SH
  • Caption Management, LLC 1,000,000 SH
  • CITIGROUP INC 503,700 SH
  • Point72 Asset Management, L.P. 500,000 SH
  • CAPSTONE INVESTMENT ADVISORS, LLC 407,000 SH
  • Jupiter Topco LLC 349,743 SH
  • Y-Intercept (Hong Kong) Ltd 170,924 SH
  • OCCUDO QUANTITATIVE STRATEGIES LP 161,933 SH
  • Dakota Wealth Management 143,066 SH
  • Mariner, LLC 121,423 SH
  • NOMURA HOLDINGS INC 83,942 SH
  • K.J. Harrison Partners Inc 75,000 SH
  • Numerai GP LLC 60,198 SH
  • NOMURA HOLDINGS INC 55,400 SH
  • Marathon Partners Equity Management, LLC 50,000 SH
  • MIRABELLA FINANCIAL SERVICES LLP 44,363 SH
  • COBALT CAPITAL MANAGEMENT, INC. 30,000 SH
  • DARK FOREST CAPITAL MANAGEMENT LP 27,942 SH
  • Virtu Financial LLC 25,121 SH
  • RENAISSANCE TECHNOLOGIES LLC 22,400 SH
  • Cambridge Investment Research Advisors, Inc. 20,600 SH
  • Blackstone Inc. 19,569 SH
  • OXFORD ASSET MANAGEMENT LLP 16,023 SH
  • MYDA Advisors LLC 15,000 SH
  • SG Americas Securities, LLC 14,655 SH
  • Fortis Capital Management LLC 14,007 SH
  • HSBC HOLDINGS PLC 11,787 SH
  • McAdam, LLC 11,409 SH
  • Amundi 11,038 SH
  • Integrated Wealth Concepts LLC 7,726 SH
  • Aster Capital Management (DIFC) Ltd 5,731 SH
  • BOUSSARD GAVAUDAN GESTION SAS 1,000 SH
  • THURSTON, SPRINGER, MILLER, HERD TITAK, INC. 600 SH
  • HIGHLINE WEALTH PARTNERS LLC 490 SH
  • FIDUCIARY FINANCIAL ADVISORS 24 SH
  • NATIONAL BANK OF CANADA /FI/ 21 SH
  • HFM Investment Advisors, LLC 2 SH
  • LifeSteps Financial, Inc. 1 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Jericho Capital Asset Management L.P. Common Shares, no par value per share0.000.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001172661-26-005353 Dispute this row
Josh Resnick Common Shares, no par value per share0.000.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0001172661-26-005353 Dispute this row
MHR INSTITUTIONAL PARTNERS III LP Common Shares, no par value0007/08/2026 Filed 2026-07-09SCHEDULE 13D/AAmendment 2Open filing 0001193125-26-299128 Dispute this row
MHR INSTITUTIONAL ADVISORS III LLC Common Shares, no par value3.811,154,68007/08/2026 Filed 2026-07-09SCHEDULE 13D/AAmendment 2Open filing 0001193125-26-299128 Dispute this row
MHR SUN GP LLC Common Shares, no par value5.716,476,84307/08/2026 Filed 2026-07-09SCHEDULE 13D/AAmendment 2Open filing 0001193125-26-299128 Dispute this row
The Rachesky Revocable Trust Common Shares, no par value5.716,476,84307/08/2026 Filed 2026-07-09SCHEDULE 13D/AAmendment 2Open filing 0001193125-26-299128 Dispute this row
MHR FUND MANAGEMENT LLC Common Shares, no par value13.037,648,49807/08/2026 Filed 2026-07-09SCHEDULE 13D/AAmendment 2Open filing 0001193125-26-299128 Dispute this row
MHR HOLDINGS LLC Common Shares, no par value13.037,648,49807/08/2026 Filed 2026-07-09SCHEDULE 13D/AAmendment 2Open filing 0001193125-26-299128 Dispute this row
Mark H. Rachesky, M.D. Common Shares, no par value13.037,910,71007/08/2026 Filed 2026-07-09SCHEDULE 13D/AAmendment 2Open filing 0001193125-26-299128 Dispute this row
FMR LLC COMMON STOCK6.719,347,894.8406/30/2026 Filed 2026-08-06SCHEDULE 13G/AAmendment 1Open filing 0000315066-26-002047 Dispute this row
Abigail P. Johnson COMMON STOCK6.719,347,894.8406/30/2026 Filed 2026-08-06SCHEDULE 13G/AAmendment 1Open filing 0000315066-26-002047 Dispute this row
FMR LLC COMMON STOCK5.114,756,168.1404/27/2026 Filed 2026-05-01SCHEDULE 13GOpen filing 0000315066-26-000740 Dispute this row
Abigail P. Johnson COMMON STOCK5.114,756,168.1404/27/2026 Filed 2026-05-01SCHEDULE 13GOpen filing 0000315066-26-000740 Dispute this row
Jericho Capital Asset Management L.P. Common Shares, no par value per share6.518,815,105.0003/31/2026 Filed 2026-05-15SCHEDULE 13GOpen filing 0001172661-26-002295 Dispute this row
Josh Resnick Common Shares, no par value per share6.518,815,105.0003/31/2026 Filed 2026-05-15SCHEDULE 13GOpen filing 0001172661-26-002295 Dispute this row
Point72 Asset Management, L.P. Common Shares, no par value per share2.46,844,626.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-003463 Dispute this row
Point72 Capital Advisors, Inc. Common Shares, no par value per share2.46,844,626.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-003463 Dispute this row
Steven A. Cohen Common Shares, no par value per share2.46,844,626.0003/31/2026 Filed 2026-05-15SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-003463 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-27SCHEDULE 13G/AAmendment 1Open filing 0000102909-26-001811 Dispute this row
Liberty 77 Capital L.P. Common Shares13.037,548,125.0001/26/2026 Filed 2026-01-27SCHEDULE 13D/AAmendment 2Open filing 0000950142-26-000238 Dispute this row
Liberty 77 Fund L.P. Common Shares2.88,136,437.0001/26/2026 Filed 2026-01-27SCHEDULE 13D/AAmendment 2Open filing 0000950142-26-000238 Dispute this row
Liberty 77 Fund International L.P. Common Shares10.229,411,688.0001/26/2026 Filed 2026-01-27SCHEDULE 13D/AAmendment 2Open filing 0000950142-26-000238 Dispute this row
Liberty 77 Capital Partners L.P. Common Shares13.037,548,125.0001/26/2026 Filed 2026-01-27SCHEDULE 13D/AAmendment 2Open filing 0000950142-26-000238 Dispute this row
Liberty Capital L.L.C. Common Shares13.037,548,125.0001/26/2026 Filed 2026-01-27SCHEDULE 13D/AAmendment 2Open filing 0000950142-26-000238 Dispute this row
STM Partners LLC Common Shares13.037,548,125.0001/26/2026 Filed 2026-01-27SCHEDULE 13D/AAmendment 2Open filing 0000950142-26-000238 Dispute this row
Steven T. Mnuchin Common Shares13.037,548,125.0001/26/2026 Filed 2026-01-27SCHEDULE 13D/AAmendment 2Open filing 0000950142-26-000238 Dispute this row
MHR INSTITUTIONAL PARTNERS III LP Common Shares, no par value8.725,173,882.0001/26/2026 Filed 2026-01-27SCHEDULE 13D/AAmendment 1Open filing 0001193125-26-023369 Dispute this row
MHR Institutional Advisors III LLC Common Shares, no par value8.725,173,882.0001/26/2026 Filed 2026-01-27SCHEDULE 13D/AAmendment 1Open filing 0001193125-26-023369 Dispute this row
MHR Fund Management LLC Common Shares, no par value13.037,648,498.0001/26/2026 Filed 2026-01-27SCHEDULE 13D/AAmendment 1Open filing 0001193125-26-023369 Dispute this row
MHR HOLDINGS LLC Common Shares, no par value13.037,648,498.0001/26/2026 Filed 2026-01-27SCHEDULE 13D/AAmendment 1Open filing 0001193125-26-023369 Dispute this row
Mark H. Rachesky, M.D. Common Shares, no par value13.137,920,093.0001/26/2026 Filed 2026-01-27SCHEDULE 13D/AAmendment 1Open filing 0001193125-26-023369 Dispute this row
Point72 Asset Management, L.P. Common Shares, no par value per share5.114,668,213.0010/31/2025 Filed 2025-11-03SCHEDULE 13GOpen filing 0000902664-25-004714 Dispute this row
Point72 Capital Advisors, Inc. Common Shares, no par value per share5.114,668,213.0010/31/2025 Filed 2025-11-03SCHEDULE 13GOpen filing 0000902664-25-004714 Dispute this row
Steven A. Cohen Common Shares, no par value per share5.114,668,213.0010/31/2025 Filed 2025-11-03SCHEDULE 13GOpen filing 0000902664-25-004714 Dispute this row
The Vanguard Group Common Stock8.2423,569,55006/30/2025 Filed 2025-07-29SCHEDULE 13GOpen filing 0000932471-25-000732 Dispute this row
BlackRock, Inc. Common Stock5.114,498,60606/30/2025 Filed 2025-07-17SCHEDULE 13GOpen filing 0002052113-25-002957 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,655,474 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201572,561
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,123

Filings made before the SEC required XML are listed, not extracted.

Back to Lionsgate Studios Corp.